Non-relapsing Secondary Progressive Multiple Sclerosis
Neurology
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 1(1)
| Drug | Company |
|---|---|
| Tolebrutinib | Sanofi (SNY) |
Frequently asked questions
How many drugs are in development for Non-relapsing Secondary Progressive Multiple Sclerosis?
BioSniper tracks 1 drug in development for Non-relapsing Secondary Progressive Multiple Sclerosis across 1 company.
How many clinical trials target Non-relapsing Secondary Progressive Multiple Sclerosis?
There are 1 clinical trial targeting Non-relapsing Secondary Progressive Multiple Sclerosis tracked by BioSniper.
Deep-dive into Non-relapsing Secondary Progressive Multiple Sclerosis
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis